Glucose Monitoring: An Evolving Landscape

Slides:



Advertisements
Similar presentations
Do you require any assistance? Do you experience any symptoms? Calit2 Summer Research Program Minimize Hypoglycemic Episodes Utilizing Remote Assistance.
Advertisements

Using Wireless Technology and the Internet to Improve Patient Outcomes.
1 Aging Services Technologies: Policy and Provider Landscape David Lindeman, PhD Assembly Committee on Aging and Long-Term Care Senate Subcommittee on.
Continuous Glucose Monitoring
Management Tools and CGM Kathryn Moe, RN CDE Medtronic Diabetes.
GENE THERAPY FOR DIABETES Lindsey Rowbotham Period 7.
Diabetes Technology Update
Naseem Sohpal Lead Diabetes Specialist Nurse
Avalere Health LLC | The intersection of business strategy and public policy Medicare Prescription Drug Payment Presented by Margaret Nowak September 24,
Identify barriers to effective patient teaching. Identify and teach to the standards of medical care for the management of Type 2 diabetes Describe the.
[START WITH A PATIENT STORY – something compelling that demonstrates the value of diabetes education.] This patient’s story illustrates why I’m passionate.
MTM Medication Therapy Management. What is Medication Therapy Management? From 1996 to 2006, the number of prescription medications dispensed increased.
Dr Zaranyika MBChB(Hons) UZ, MPH, FCP SA Department of Medicine UZ-CHS
Department of Public Health Presentation to the Health Cabinet June 14, 2016.
HCA 375 Week 1 DQ 2 Implementation and Barriers Check this A+ tutorial guideline at implementation-and-barriers.
Antimicrobial Stewardship
Medication therapy management
Medication Therapy Management (MTM)
SB 493: Ordering Tests Team 6.
Introduction to Clinical Pharmacy
Extending Metformin Use in Diabetic Kidney Disease: A Pharmacokinetic Study in Stage 4 Diabetic Nephropathy  Ajith Munasinghe Dissanayake, Mark Christopher.
Chart 1.17: Medicare Enrollees,(1) 1995 – 2015
Insulin Pump Continuation in the Hospital
Type 1 Diabetes: Meters, Pumps, and Transitions to Adulthood
Engaging the INSULIN-TREATED T2DM Patient: the Importance of Real-World Data.
HCA 375 HELP Education for Service-- hca375help.com.
The Nurse View: Hormone Receptor-Positive Advanced Breast Cancer
Why Gene Therapy for Hemophilia?
Lifestyle and Professional CGM
Battery life of transmitter is a minimum of 6 months.
Faster-Acting Insulins
Medical Practices as Small Business:
Program Goals. Inhaled Insulin: Overcoming Past Obstacles With Advances in Understanding.
Using the AGP to Standardize Glucose Reporting
LBL Rev 01.
A review of the new Eversense CGM System
Continuous Subcutaneous Insulin Infusion (CSII) [Insulin Pump]
Utilizing New Technologies and Insulins for a Tighter Grip on PPG
Best Practices in Advanced Glucose Monitoring
SGLT2 Inhibitors in the Modern Era: Why and Where?
Updates to Managing Diabetes in the Long-Term Care Setting
Strategies to Improve Adherence and Persistence in the Treatment of Hypertension.
Heart Failure Management Coordinated Care Approaches
Blood pressure control: dependence on adherence
Integrated Diabetes Care: How Can We Make the Best Use of New Technology?
Individualizing Factor Replacement Therapy for Patients With Hemophilia.
Understanding PAD.
Provider and Member Education in Managed Care Pharmacy
Advancing the Treatment of IBD With Biologics
Simplifying Insulin Delivery for Better Patient Outcomes in T2D
The Primary Care Guide to New CGM Devices and the AGP
Novel Insulin/GLP-1 Combinations: Of Interest to the Primary Care Physician?
Modern Advances in Glucose Monitoring
Pharmacist Involvement in Continuous Glucose Monitoring
Younger Patients With Type 1 Diabetes: Can We Optimize Their Insulin Therapy?
Panelists. Cardiovascular Risk Modulation in Diabetes: Emerging Pathways and Insights.
Advancements in Glucose Monitoring
Hypoglycemia: The Most Common Barrier to Effective Diabetes Management
NP and PA Expert Exchange:
Improving Adherence to Antiplatelet Therapy After an ACS Event
Cystic fibrosis related diabetes in an extremely young patient
Evan S. Drake, Danielle K. Harris, Macary Weck Marciniak 
Oral Therapies in MS.
Pathogenesis of IBD, and the Role of Biologic Therapies
Mitigating Side Effects and Optimizing Compliance With Oral Therapies in CLL.
Fixed-Ratio Combination Therapy in T2DM
The continuous line represents the sensor glucose values.
New Advances in Hybrid Closed-Loop Control of Insulin Therapy
Based on personal experience, conversations with experts, and a literature review, this is a partial list of factors that can affect blood glucose. Based.
Fresh perspectives ON BASAL Insulins in diabetes care
Presentation transcript:

The Pharmacist’s Role in Advancing Glucose Monitoring With New Technologies

Glucose Monitoring: An Evolving Landscape

Benefits of CGM Therapy

Blood Glucose Meter and CGM

Interpreting and Using CGM Data

CGM Trend Arrows and Curves

Pharmacists Can Help Promote Adherence to CGM

Match a CGM Device to Each Patient

REPLACE-BG Study

REPLACE-BG Study Adverse Events Summary

Therapeutic Insulin Dosing

Flash Glucose Monitoring

Physiologic Lag Time in Measurement

Updated US Centers for Medicare & Medicaid Services (CMS) Coverage and Coding

Who Benefits From CGM

There Is a Need for a Standardized Glucose Report

Development of the AGP

Standardization of Reporting (With AGP) Mentioned by Major Societies

The AGP Can Help Simplify the Patient’s Life

The AGP Collapses Glucose Data From a 2-Week Period

The AGP: a 1-Page Report

Adoption of the AGP in Modern and Standardized CGM

The Pharmacist Can Aid Understanding and Utilization of CGM and the AGP Report

Patient and Healthcare Provider Education

Closing Remarks

Abbreviations